These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 1915820

  • 1. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ, Edge MT, Freeman AM.
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M, Stern RG.
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A, Rüster P, Romero B, Zimmer R.
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological correction of Alzheimer's disease (review of the literature)].
    Groppa SA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991 Oct; 91(9):110-6. PubMed ID: 1686127
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
    Olazarán J, García G.
    Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alzheimer's dementia: recent developments in cholinergic pharmacology.
    Moss DE, Rodriguez LA.
    Tex Med; 1987 Jan; 83(1):32-4. PubMed ID: 3824230
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treating Alzheimer's disease with cholinergic drugs, Part I.
    Terpstra T, Terpstra T.
    Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B, Messamore E, O'Neill C, Cowburn R.
    Acta Neurol Scand Suppl; 1993 Nov; 149():4-6. PubMed ID: 8128837
    [Abstract] [Full Text] [Related]

  • 20. [The use of acetylcholinesterase inhibitors in Alzheimer's disease].
    Parnowski T.
    Przegl Lek; 2001 Nov; 58 Suppl 3():2-6. PubMed ID: 11603170
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.